Sepsis frequently results in acute kidney injury (AKI). Although AKI markedly contributes to mortality in sepsis, its diagnosis is frequently delayed due to limitations of current biomarkers of renal impairment. Neutrophil-gelatinase-associated lipocalin (NGAL) has been demonstrated to be a biomarker of early AKI.
To download as pdf please click hereRead more
BioPorto Diagnostics has launched a new ELISA test for the determination of the acute kidney injury marker NGAL in rats.Read more